- Home
- DOGZ vs OBIO Comparison
DOGZ vs OBIO Comparison
Compare DOGZ & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOGZ
- OBIO
- Stock Information
- Founded
- DOGZ 2003
- OBIO 2017
- Country
- DOGZ China
- OBIO United States
- Employees
- DOGZ N/A
- OBIO N/A
- Industry
- DOGZ Miscellaneous manufacturing industries
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- DOGZ Consumer Discretionary
- OBIO Health Care
- Exchange
- DOGZ Nasdaq
- OBIO Nasdaq
- Market Cap
- DOGZ 165.1M
- OBIO 146.2M
- IPO Year
- DOGZ 2017
- OBIO N/A
- Fundamental
- Price
- DOGZ $13.45
- OBIO $2.70
- Analyst Decision
- DOGZ
- OBIO Strong Buy
- Analyst Count
- DOGZ 0
- OBIO 4
- Target Price
- DOGZ N/A
- OBIO $14.00
- AVG Volume (30 Days)
- DOGZ 677.8K
- OBIO 222.4K
- Earning Date
- DOGZ 10-24-2025
- OBIO 11-11-2025
- Dividend Yield
- DOGZ N/A
- OBIO N/A
- EPS Growth
- DOGZ N/A
- OBIO N/A
- EPS
- DOGZ N/A
- OBIO N/A
- Revenue
- DOGZ $20,258,926.00
- OBIO $2,944,000.00
- Revenue This Year
- DOGZ N/A
- OBIO $29.26
- Revenue Next Year
- DOGZ N/A
- OBIO $10.65
- P/E Ratio
- DOGZ N/A
- OBIO N/A
- Revenue Growth
- DOGZ 46.16
- OBIO 41.61
- 52 Week Low
- DOGZ $6.81
- OBIO $2.20
- 52 Week High
- DOGZ $58.50
- OBIO $6.50
- Technical
- Relative Strength Index (RSI)
- DOGZ 52.31
- OBIO 55.64
- Support Level
- DOGZ $13.08
- OBIO $2.20
- Resistance Level
- DOGZ $13.60
- OBIO $2.89
- Average True Range (ATR)
- DOGZ 0.74
- OBIO 0.14
- MACD
- DOGZ -0.06
- OBIO 0.04
- Stochastic Oscillator
- DOGZ 59.74
- OBIO 74.45
About DOGZ Dogness (International) Corporation
Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.